Gujarat Themis Biosyn Ltd

NSE: GUJTHEM · BSE: 506879 · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹417.00
Market cap: ₹5,427 Cr
Revenue (annual): ₹165.8 Cr
Net profit (annual): ₹46.68 Cr
P/E (TTM): 111.5×Sector 50.4×
Promoter holding: 59.33%-11.53% QoQ
FII holding: 4.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 3 Debt & Borrowing 2 Annual General Meeting 2 Acquisition 2 Other Announcement 1 Dividend 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

18 Sep 2026 19:01 IST BSE

Acquisition

Gujarat Themis Biosyn Acquisition Worth ₹1,300 Cr

Gujarat Themis Biosyn Limited acquired MicroBiopharm Japan Co. Ltd. for approximately ₹1,300 Crore. This acquisition expands its pharmaceutical CDMO capabilities.

Value: ₹1,300 Cr

Read the filing ↗

18 Sep 2026 10:31 IST BSE

Acquisition

Gujarat Themis Biosyn Acquisition Worth ₹1,333 Cr

GTBL completed 100% acquisition of MBJ Japan for JPY 21.5 billion (~₹1,333 Cr). The deal adds three GMP plants and precision fermentation capabilities.

Value: ₹1,333 Cr
GMP-compliant manufacturing plants: 3 plants

Read the filing ↗